Equities

ImageOne Co Ltd

2667:TYO

ImageOne Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)183.00
  • Today's Change-2.00 / -1.08%
  • Shares traded90.60k
  • 1 Year change-69.45%
  • Beta1.7806
Data delayed at least 20 minutes, as of Oct 16 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in JPYIncome statement in JPYView more

Year on year ImageOne Co Ltd's revenues fell -13.30%from 3.43bn to 2.98bn. In addition, the company has been unable to reduce the cost of goods sold, selling, general and administrative expenses and interest paid (all as a percentage of sales). This has contributed to a 89.71% reduction in net income from a loss of 341.51m to a larger loss of 647.89m.
Gross margin1.00%
Net profit margin-61.58%
Operating margin-59.71%
Return on assets-38.42%
Return on equity-58.21%
Return on investment-57.52%
More ▼

Cash flow in JPYView more

In 2023, ImageOne Co Ltd increased its cash reserves by 31.01%, or 195.48m. Cash Flow from Investing totalled 247.38m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company generated 39.11m in cash from operations while cash used for financing totalled 91.02m.
Cash flow per share-93.75
Price/Cash flow per share--
Book value per share116.44
Tangible book value per share115.72
More ▼

Balance sheet in JPYView more

ImageOne Co Ltd uses little debt in its capital structure as supported by a debt to capital ratio of 1.48%.
Current ratio1.95
Quick ratio1.51
Total debt/total equity0.015
Total debt/total capital0.0148
More ▼

Growth rates in JPY

Year on year, growth in earnings per share excluding extraordinary items dropped -81.33%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
-248.16
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.